Diabetic Vascular Complications: Pathophysiology, Biochemical Basis and Potential Therapeutic Strategy

E-ISSN： 1873-4286|11|18|2279-2299

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.18, 2005-07, pp. : 2279-2299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Involvement of the Toxic AGEs (TAGE)-RAGE System in the Pathogenesis of Diabetic Vascular Complications: A Novel Therapeutic Strategy

Current Drug Targets, Vol. 11, Iss. 11, 2010-01 ,pp. : 1468-1482

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Potential New Therapeutic Strategies of Diabetic Vascular Complications (Guest Editor: Toyoshi Inoguchi)]

Current Drug Targets, Vol. 6, Iss. 4, 2005-06 ,pp. : 445-446

Bentham Science Publishers

Access to resources Recommend Favorite

Pigment Epithelium-Derived Factor (PEDF): Its Potential Therapeutic Implication in Diabetic Vascular Complications

Current Drug Targets, Vol. 9, Iss. 11, 2008-11 ,pp. : 1025-1029

Bentham Science Publishers

Access to resources Recommend Favorite

The Therapeutic Potential of VEGF Inhibition in Diabetic Microvascular Complications

By Tremolada Gemma

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 6, 2007-01 ,pp. : 393-398

Adis International

Access to resources Recommend Favorite

Molecular Targets of Diabetic Vascular Complications and Potential New Drugs

Current Drug Targets, Vol. 6, Iss. 4, 2005-06 ,pp. : 503-509

Bentham Science Publishers

Access to resources Recommend Favorite